cell-based luciferase reporter gene assay Search Results


cell-based luciferase reporter gene assay  (Promega)
90
Promega cell-based luciferase reporter gene assay
The Y150-dependence of <t>gene</t> activation of Jurkat cells: in presence of Jurkat-CD3-NFAT-RE-Luc cells only (in Green), or in presence of Jurkat-CD38 − -CD3-NFAT-RE-Luc cells only (Jurkat-4-3-F11, in Brown), or in presence of both Jurkat-CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Red), or in presence of both Jurkat- CD38 − -CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Blue). In the <t>reporter</t> gene <t>assay,</t> Jurkat cells (effector cells) and NCI-H929 (target cells) were in a ratio of 1.5:1 (E:T).
Cell Based Luciferase Reporter Gene Assay, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell-based luciferase reporter gene assay/product/Promega
Average 90 stars, based on 1 article reviews
cell-based luciferase reporter gene assay - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cell-based luciferase reporter gene systems  (Xenova Group)
90
Xenova Group cell-based luciferase reporter gene systems
The Y150-dependence of <t>gene</t> activation of Jurkat cells: in presence of Jurkat-CD3-NFAT-RE-Luc cells only (in Green), or in presence of Jurkat-CD38 − -CD3-NFAT-RE-Luc cells only (Jurkat-4-3-F11, in Brown), or in presence of both Jurkat-CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Red), or in presence of both Jurkat- CD38 − -CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Blue). In the <t>reporter</t> gene <t>assay,</t> Jurkat cells (effector cells) and NCI-H929 (target cells) were in a ratio of 1.5:1 (E:T).
Cell Based Luciferase Reporter Gene Systems, supplied by Xenova Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell-based luciferase reporter gene systems/product/Xenova Group
Average 90 stars, based on 1 article reviews
cell-based luciferase reporter gene systems - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cell-based assay consisting of erythroleukaemic k562 cells transfected with a nfκb-regulated firefly luciferase reporter–gene construct  (Biomonitor)
90
Biomonitor cell-based assay consisting of erythroleukaemic k562 cells transfected with a nfκb-regulated firefly luciferase reporter–gene construct
The Y150-dependence of <t>gene</t> activation of Jurkat cells: in presence of Jurkat-CD3-NFAT-RE-Luc cells only (in Green), or in presence of Jurkat-CD38 − -CD3-NFAT-RE-Luc cells only (Jurkat-4-3-F11, in Brown), or in presence of both Jurkat-CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Red), or in presence of both Jurkat- CD38 − -CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Blue). In the <t>reporter</t> gene <t>assay,</t> Jurkat cells (effector cells) and NCI-H929 (target cells) were in a ratio of 1.5:1 (E:T).
Cell Based Assay Consisting Of Erythroleukaemic K562 Cells Transfected With A Nfκb Regulated Firefly Luciferase Reporter–Gene Construct, supplied by Biomonitor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell-based assay consisting of erythroleukaemic k562 cells transfected with a nfκb-regulated firefly luciferase reporter–gene construct/product/Biomonitor
Average 90 stars, based on 1 article reviews
cell-based assay consisting of erythroleukaemic k562 cells transfected with a nfκb-regulated firefly luciferase reporter–gene construct - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


The Y150-dependence of gene activation of Jurkat cells: in presence of Jurkat-CD3-NFAT-RE-Luc cells only (in Green), or in presence of Jurkat-CD38 − -CD3-NFAT-RE-Luc cells only (Jurkat-4-3-F11, in Brown), or in presence of both Jurkat-CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Red), or in presence of both Jurkat- CD38 − -CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Blue). In the reporter gene assay, Jurkat cells (effector cells) and NCI-H929 (target cells) were in a ratio of 1.5:1 (E:T).

Journal: Antibody Therapeutics

Article Title: Development of a reporter gene method to measure the bioactivity of anti-CD38 × CD3 bispecific antibody

doi: 10.1093/abt/tbab022

Figure Lengend Snippet: The Y150-dependence of gene activation of Jurkat cells: in presence of Jurkat-CD3-NFAT-RE-Luc cells only (in Green), or in presence of Jurkat-CD38 − -CD3-NFAT-RE-Luc cells only (Jurkat-4-3-F11, in Brown), or in presence of both Jurkat-CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Red), or in presence of both Jurkat- CD38 − -CD3-NFAT-RE-Luc cells and NCI-H929 cells (in Blue). In the reporter gene assay, Jurkat cells (effector cells) and NCI-H929 (target cells) were in a ratio of 1.5:1 (E:T).

Article Snippet: Promega Corporation developed a cell-based luciferase reporter gene assay to monitor the Jurkat T cell activation through binding to CD3 on the Jurkat T cells engineered with an nuclear factor of activated T cells response element (NFAT-RE) driving luciferase expression [ , ].

Techniques: Activation Assay, Reporter Gene Assay

Validation of reporter gene assay. (A) Specificity assessment of the assay. Y150 or a nonspecific antibody was incubated with both NCI-H929 cells and Jurkat T cell line 4-3-F11, and the RLU signals were measured. Y150 sample stressed under oxidization with 4% hydrogen peroxide was tested and compared with Y150 reference sample. (B) Analysis of linearity of the assay was conducted by comparing the measured potency and expected potency. Each point represents the mean of six independent experiments.

Journal: Antibody Therapeutics

Article Title: Development of a reporter gene method to measure the bioactivity of anti-CD38 × CD3 bispecific antibody

doi: 10.1093/abt/tbab022

Figure Lengend Snippet: Validation of reporter gene assay. (A) Specificity assessment of the assay. Y150 or a nonspecific antibody was incubated with both NCI-H929 cells and Jurkat T cell line 4-3-F11, and the RLU signals were measured. Y150 sample stressed under oxidization with 4% hydrogen peroxide was tested and compared with Y150 reference sample. (B) Analysis of linearity of the assay was conducted by comparing the measured potency and expected potency. Each point represents the mean of six independent experiments.

Article Snippet: Promega Corporation developed a cell-based luciferase reporter gene assay to monitor the Jurkat T cell activation through binding to CD3 on the Jurkat T cells engineered with an nuclear factor of activated T cells response element (NFAT-RE) driving luciferase expression [ , ].

Techniques: Reporter Gene Assay, Incubation

The correlations of reporter gene assay results with those from cytotoxicity assay and sandwich ELISA assay

Journal: Antibody Therapeutics

Article Title: Development of a reporter gene method to measure the bioactivity of anti-CD38 × CD3 bispecific antibody

doi: 10.1093/abt/tbab022

Figure Lengend Snippet: The correlations of reporter gene assay results with those from cytotoxicity assay and sandwich ELISA assay

Article Snippet: Promega Corporation developed a cell-based luciferase reporter gene assay to monitor the Jurkat T cell activation through binding to CD3 on the Jurkat T cells engineered with an nuclear factor of activated T cells response element (NFAT-RE) driving luciferase expression [ , ].

Techniques: Reporter Gene Assay, Cytotoxicity Assay, Sandwich ELISA